AIG
AST

American International Group’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

American International Group’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-18,910
Closed -$27K – 3212
2018
Q1 		$27K Sell
18,910
-1,017
-5% -$2.12K ﹤0.01% 2979
2017
Q4 		$45K Buy
19,927
+1,851
+10% +$4.68K ﹤0.01% 2958
2017
Q3 		$61K Buy
18,076
+1,352
+8% +$4.55K ﹤0.01% 2776
2017
Q2 		$59K Buy
16,724
+2,772
+20% +$9.13K ﹤0.01% 2964
2017
Q1 		$47K Buy
13,952
+926
+7% +$3.6K ﹤0.01% 2855
2016
Q4 		$60K Sell
13,026
-32
-0.2% -$132 ﹤0.01% 2819
2016
Q3 		$55.4K Hold
13,058
– – ﹤0.01% 2871
2016
Q2 		$31.3K Buy
13,058
+6,829
+110% +$24.7K ﹤0.01% 3023
2016
Q1 		$29K Hold
6,229
– – ﹤0.01% 4156
2015
Q4 		$24K Sell
6,229
-11
-0.2% -$51 ﹤0.01% 4234
2015
Q3 		$24K Buy
6,240
+7
+0.1% +$32 ﹤0.01% 4231
2015
Q2 		$28.7K Buy
6,233
+4,936
+381% +$47.3K ﹤0.01% 4256
2015
Q1 		$8.74K Sell
1,297
-833
-39% -$4.13K ﹤0.01% 4579
2014
Q4 		$6.89K Buy
+2,130
New +$8.57K ﹤0.01% 4626

Other funds holding AST

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

American International Group's AST Position: Q2 2018 in Review

American International Group sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q2 2018, closing a stake of 18,910 shares — an estimated $27K sold.

American International Group first reported a position in AST in Q4 2014 and held it in 14 quarters. The position peaked at $61K in Q3 2017. 62 funds tracked by Wall St. Rank hold AST as of Q2 2018.

  • American International Group reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q2 2018 after selling out during the quarter.
  • American International Group sold 18,910 Asterias Biotherapeutics Inc. Series A shares in Q2 2018, an estimated $27K.
  • American International Group first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2014 and held it in 14 quarters.
  • American International Group's Asterias Biotherapeutics Inc. Series A position peaked at $61K in Q3 2017.
  • 62 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q2 2018.

Based on American International Group's 13F filing for Q2 2018, filed 8 Aug 2018.